Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04666688
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2020-11-25
Brief Title:
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor:
PureTech
Organization:
PureTech
Organization Data
Organization:
PureTech
Class:
INDUSTRY
Study ID:
LYT-200-2020-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PureTech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None